Methyl5-(3-chlorophenyl)isoxazole-3-carboxylate
98%
- Product Code: 213729
CAS:
660417-41-4
Molecular Weight: | 237.64 g./mol | Molecular Formula: | C₁₁H₈ClNO₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. It serves as a building block for modulating biological activity in drug candidates targeting neurological disorders. Its structural features allow for derivatization to enhance binding affinity and selectivity in medicinal chemistry programs. Commonly employed in research settings for the preparation of analogs in structure-activity relationship (SAR) studies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿5,860.00 |
+
-
|
250mg | 10-20 days | ฿9,760.00 |
+
-
|
1g | 10-20 days | ฿19,500.00 |
+
-
|
5g | 10-20 days | ฿58,490.00 |
+
-
|
Methyl5-(3-chlorophenyl)isoxazole-3-carboxylate
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. It serves as a building block for modulating biological activity in drug candidates targeting neurological disorders. Its structural features allow for derivatization to enhance binding affinity and selectivity in medicinal chemistry programs. Commonly employed in research settings for the preparation of analogs in structure-activity relationship (SAR) studies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :